公司資料
Veradigm 股價、新聞與催化劑
- 股票代碼:
- MDRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.99 USD (+1.84%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
The latest company update was “Veradigm to Participate in Two Upcoming Investor Conferences”. MDRX changed 1.84% and closed at $4.99 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this company update.
公司概覽
業務概覽
Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Veradigm sits in healthcare IT.
商業模式特徵
Revenue depends on software subscriptions, data products, and the commercialization of workflow tools across healthcare users.
生技產業定位
Veradigm is outside biotech and belongs to the healthcare information layer, where software adoption and execution matter most.
未來催化劑
- Veradigm's catalysts are claims-data products, payer and life-science software demand, and any operating update that clarifies the turnaround path. The company is still a software-and-data execution story.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。